These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 21524238)

  • 1. Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
    Hochberg MC; Fort JG; Svensson O; Hwang C; Sostek M
    Curr Med Res Opin; 2011 Jun; 27(6):1243-53. PubMed ID: 21524238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
    Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
    Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and durability of pain relief in knee osteoarthritis: pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
    Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
    Phys Sportsmed; 2015 Aug; ():1-13. PubMed ID: 26235613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study.
    Essex MN; O'Connell MA; Behar R; Bao W
    Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial.
    Essex MN; Bhadra P; Sands GH
    J Int Med Res; 2012; 40(4):1357-70. PubMed ID: 22971487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee.
    Essex MN; O'Connell M; Bhadra Brown P
    J Int Med Res; 2012; 40(6):2251-66. PubMed ID: 23321182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
    Rother M; Lavins BJ; Kneer W; Lehnhardt K; Seidel EJ; Mazgareanu S
    Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
    Scheinberg M; Pott Júnior H; Macêdo EA; Bocchi de Oliveira MF; Ecclissato C; Amazonas RB
    Drug Des Devel Ther; 2018; 12():2775-2783. PubMed ID: 30233140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
    Angiolillo DJ; Datto C; Raines S; Yeomans ND
    J Thromb Thrombolysis; 2014 Jul; 38(1):11-23. PubMed ID: 24368727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
    Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
    Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
    Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
    Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.
    Schnitzer TJ; Ekman EF; Spierings EL; Greenberg HS; Smith MD; Brown MT; West CR; Verburg KM
    Ann Rheum Dis; 2015 Jun; 74(6):1202-11. PubMed ID: 24625625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis.
    Park MS; Kang CN; Lee WS; Kim HJ; Lee S; Kim JH; Shin SJ; Moon SH
    PLoS One; 2020; 15(1):e0226184. PubMed ID: 31986170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
    Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
    J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naproxen/esomeprazole fixed-dose combination: for the treatment of arthritic symptoms and to reduce the risk of gastric ulcers.
    Dhillon S
    Drugs Aging; 2011 Mar; 28(3):237-48. PubMed ID: 21329403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
    Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
    Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
    Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
    Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.